0001628280-19-004973.txt : 20190429 0001628280-19-004973.hdr.sgml : 20190429 20190429183309 ACCESSION NUMBER: 0001628280-19-004973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190425 FILED AS OF DATE: 20190429 DATE AS OF CHANGE: 20190429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLARK IAN T CENTRAL INDEX KEY: 0001336504 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 19777645 MAIL ADDRESS: STREET 1: SOLAZYME, INC. STREET 2: 225 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 wf-form4_155657717448512.xml FORM 4 X0306 4 2019-04-25 0 0001576280 Guardant Health, Inc. GH 0001336504 CLARK IAN T 505 PENOBSCOT DRIVE REDWOOD CITY CA 94063 1 0 0 0 COMMON STOCK 2019-04-25 4 M 0 538 4.18 A 538 D COMMON STOCK 2019-04-25 4 S 0 538 65.11 D 0 D STOCK OPTION (RIGHT TO BUY) 4.18 2019-04-25 4 M 0 538 0 D 2027-11-29 COMMON STOCK 538.0 16140 D These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on October 25, 2017. /s/ Michael Wiley, as attorney-in-fact for Ian Clark 2019-04-29